Apr 6, 2026
Unexpected findings on lung cancer CT scans may point to other non-lung cancers, study finds“Because CT scans capture areas of the body beyond the lungs, doctors often see abnormalities that might indicate cancer in other parts of the body, including the kidneys,...
Mar 30, 2026
Next-generation therapies to outsmart drug-resistant lung cancer“The Gray Lab is developing next-gen therapies, including protein degraders and “dual-grip” inhibitors, to overcome drug resistance in lung cancer.” PFOS, PFHA, Mono-Iso-Nonyl-Phthalate Can...
Mar 23, 2026
Early diagnosis and local solutions are critical to combat lung cancer“Opinion: Despite advances in prevention and treatment, lung cancer remains the world’s deadliest cancer largely because it is often detected too late. Strengthening local diagnostic capacity is one...
Mar 16, 2026
Why lung cancer belongs in the women’s health conversation“Cancer mortality in the United States has steadily declined for more than three decades, with millions of lives saved through smoking cessation, earlier detection, and improved treatment. But the epidemiology...
Mar 2, 2026
Gaps in Lung Cancer Treatment Persist, Yale Study Finds“In recent decades, lung cancer treatment has been transformed—new surgeries, new radiation techniques, and dramatically improved outcomes. But according to new research from Yale, published in JAMA Network Open,...
Feb 24, 2026
FDA Approves Monthly Dosing for Subcutaneous Amivantamab in EGFR-Mutated NSCLC“The U.S. Food and Drug Administration has approved a once-monthly dosing schedule for frontline amivantamab and hyaluronidase-lpuj (Rybrevant Faspro), the subcutaneous formulation of the...
Feb 17, 2026
Will Offering a Blood Test to Detect Lung Cancer Improve Screening Rates?“Dr. Melinda Aldrich wants to boost screening rates to catch lung cancer earlier when it is more treatable.” Tuberculosis, Chronic Bronchitis Linked to Lung Cancer Risk in Never-Smokers“A...
Feb 10, 2026
‘Personal lives’ of lung cancer cells help predict response to treatment“University of Queensland researchers who mapped cancer cell “neighborhoods” in the most common type of lung cancer have found cell metabolism plays a critical role in...
Feb 2, 2026
Time-of-day immunochemotherapy in nonsmall cell lung cancer: a randomized phase 3 trial“In summary, our study indicates that early ToD immunochemotherapy substantially improves PFS and OS and is associated with enhanced antitumor CD8+ T cell characteristics compared...
Jan 26, 2026
Osimertinib Dose Reduction Does Not Compromise OS in EGFR-Mutated Metastatic NSCLC“Reducing osimertinib dose in the first-line treatment of EGFR-mutated metastatic non-small cell lung cancer (mNSCLC) patients due to the occurrence of adverse events has no impact on...
